Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Kalaris Therapeutics (KLRS) EPS (Basic) (2019 - 2020)

Kalaris Therapeutics (KLRS) has 2 years of EPS (Basic) data on record, last reported at $0.34 in Q4 2020.

  • For Q4 2020, EPS (Basic) rose 105.0% year-over-year to $0.34; the TTM value through Dec 2020 reached -$2.57, up 62.2%, while the annual FY2024 figure was -$11.73, 72.13% up from the prior year.
  • EPS (Basic) reached $0.34 in Q4 2020 per KLRS's latest filing, down from $5.73 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $5.73 in Q3 2020 and bottomed at -$6.8 in Q4 2019.